Previous Article | Next Article 
Journal of Virology, September 2000, p. 8119-8126, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mink Cell Focus-Forming Murine Leukemia Virus
Infection Induces Apoptosis of Thymic Lymphocytes
Fayth K.
Yoshimura,1,*
Tao
Wang,1
Fei
Yu,2
Hyeong-Reh C.
Kim,2 and
Jerrold R.
Turner2
Department of Immunology and Microbiology and
the Karmanos Cancer Institute1 and
Department of Pathology,2 Wayne State
University, Detroit, Michigan 48201
Received 9 February 2000/Accepted 1 June 2000
 |
ABSTRACT |
In a previous study we identified the subpopulations of thymus
cells that were infected by the lymphomagenic MCF13 murine leukemia
virus (MLV) (F. K. Yoshimura, T. Wang, and M. Cankovic, J. Virol. 73:4890-4898, 1999) and observed an effect on thymus size by
virus infection. In this report we describe our results which
demonstrate that MCF13 MLV infection of thymuses reduced the number of
T lymphocytes in this organ. Histological examination showed diffuse
lymphocyte depletion, which was most striking in the CD4+
CD8+ lymphocyte-enriched cortical zone. Consistent with
this, flow cytometric analysis showed that the lymphocytes which were
depleted were predominantly the immature CD3
CD4+ CD8+ and CD3+ CD4+
CD8+ cells. A comparison of the percentages of live,
apoptotic, and dead cells of the gp70+ and
gp70
thymic lymphocytes suggested that this effect on
thymus cellularity is a result of virus infection. Studies of the
survival of thymic T lymphocytes in culture showed that cells from
MCF13 MLV-inoculated mice underwent greater apoptosis and death than
cells from control animals. Assays for apoptosis included
7-amino-actinomycin D staining, DNA fragmentation, and cleavage of
caspase-3 and poly(ADP-ribose) polymerase proenzymes. Our results
suggest that apoptosis of thymic lymphocytes by virus infection is an
important step in the early stages of MCF13 MLV tumorigenesis.
 |
INTRODUCTION |
Murine leukemia viruses (MLVs) with
simple genomes require a relatively long latency for the development of
thymic lymphoma. In AKR mice, thymic tumors begin to arise when the
animals are about 6 to 7 months old (6, 29a). It is thought
that one of the reasons for this long latency in AKR mice is the
requirement for the generation of recombinant MLVs, i.e., mink cell
focus-forming (MCF) viruses, which are the proximal etiologic agent of
disease (6, 34). The oncogenic class I MCF MLVs are
recombinant retroviruses with an ecotropic MLV backbone and
nonecotropic viral sequences at the N-terminal portion of the SU
protein and the C terminus of TM and the U3 region of the long terminal
repeat (12, 28, 51). Class I MCF viruses are detectable in
the thymus of AKR mice beginning at about 4 to 5 months of age
(12, 47). Compared with the time course for the appearance
of spontaneous thymic tumors in AKR mice, MCF13 inoculation into AKR
neonates results in accelerated leukemogenesis which begins at about 10 weeks postinoculation (54). Although extensive studies have
examined the later events of MCF MLV tumorigenesis (8, 9,
36), less work has been done to study the earlier preleukemic
period. It has been observed that efficient virus replication in the
thymus during the preleukemic period is essential for thymus
development (21, 34, 35). We have recently reported that the
sequences between the enhancer and promoter (DEN) in the long terminal
repeat of the MCF13 MLV regulate virus replication in the thymus during
the early stages of lymphomagenesis (59).
As a part of this study we identified the thymic subpopulations which
were infected by MCF13 MLV. We observed that the subpopulation in which
the highest level of virus replication occurred during the preleukemic
period was the immature CD3+ CD4+
CD8+ (59). These cells accounted for 70 to 80%
of virus-infected cells. The subpopulation with the next highest
percentage (10 to 18%) of virus-infected cells was CD3
CD4+ CD8+, which are the precursors to the
CD3+ CD4+ CD8+ cells (14, 41,
44). The effect of MLV infection on CD4+
CD8+ cells has also been observed for the SL3-3 virus,
which produces thymic lymphoma similar to MCF13 (18, 27). It
has been shown that the normal development of these cells is affected
during the maturation of CD4
CD8
cells when
they were isolated from SL3-3 virus-inoculated mice and either cultured
with fetal thymic stroma in vitro or inoculated intrathymically into
mice (16, 17). The idea that thymic lymphocytes which have a
CD4+ CD8+ phenotype may be the major targets
for cellular transformation is further supported by the detection of
this phenotype for cells present in the majority of MLV-induced thymic
tumors by ourselves and other investigators (18, 26, 59).
The CD4+ CD8+ thymic subpopulation in which
MCF13 MLV replication predominantly occurs (59) is the same
subset in which both positive and negative selection of thymic T
lymphocytes normally occurs (14, 41). It has been observed
that the negative selection process involves the apoptosis of
CD4+ CD8+ cells which recognize self-antigens.
Because in our previous study we noticed that one of the effects of
MCF13 MLV infection was the reduction of thymus size, we explored the
effect of virus replication on the dynamic cellular processes of this
organ, and particularly on the CD4+ CD8+
subpopulation during the early stages of tumorigenesis. This report
summarizes the results of this study.
 |
MATERIALS AND METHODS |
Virus inoculation and isolation of thymic lymphocytes.
Neonatal AKR mice were injected intraperitoneally with 50 µl of
inoculum containing 106 infectious units (IFUs) of MCF13
MLV. Control mice were inoculated with tissue culture medium. Mice were
euthanized by CO2 inhalation and cervical dislocation, and
thymuses were removed into cold RPMI 1640 containing 2% inactivated
fetal calf serum (IFCS). Single-cell suspensions were made by pressing
the thymus tissue through a wire mesh into RPMI plus 2% IFCS. Cells
were washed once with medium without serum. The viability of thymic
lymphocytes in suspension, which was determined by trypan blue dye
exclusion, was routinely greater than 90%.
In vitro culture of thymic cells.
Single-cell suspensions of
thymic lymphocytes were placed into 75-cm2 tissue culture
flask with RPMI 1640 containing 10% IFCS and 100 µg of
penicillin-streptomycin per ml at a density of 107 cells
per ml. Cells were harvested at 6, 24, and 48 h after incubation. Cell viability was determined at each time point.
Thymus histology.
Thymuses from euthanized MCF13-inoculated
and control mice were rapidly removed and immediately fixed overnight
in 10% formalin. After dehydration in graded ethanol and xylene, the
tissues were embedded in paraffin. Serial 5-µm sections were
prepared, and alternate sections were stained by Giemsa or hematoxylin
and eosin stains.
Staining of thymic cells.
Thymic lymphocytes
(106) were washed twice with phosphate-buffered saline
(PBS) containing 1% bovine serum albumin and 0.02% sodium azide.
Washed cells were incubated with 100 µl of monoclonal antibody (MAb)
514 on ice for 30 min, after which time 100 µl of the secondary
antibody (fluorescein isothiocyanate-conjugated goat anti-mouse
immunoglobulin G [IgG]) at a 1:100 dilution was added. After being
washed twice with PBS, the cells were resuspended in 100 µl of PBS
containing hamster anti-CD3 antibody conjugated to phycoerythrin, rat
anti-CD4 antibody conjugated to Cy-Chrome, rat anti-CD8 antibody
conjugated to biotin (PharMingen), and NeutraLite avidin conjugated to
Cascade blue (Molecular Probes, Eugene, Oreg.) at dilutions previously
determined by titration assays. Washed cells were resuspended in 0.7 ml
of 0.5% paraformaldehyde and analyzed by flow cytometry.
Flow cytometric analysis.
Prior to analysis, dead cells were
gated out based on forward versus side scatter dot plots. Flow
cytometry was performed on a FACS Vantage flow cytometer equipped with
an HP 9000 computer running the LYSYS II software (Becton Dickinson
Immunocytometry Systems, San Jose, Calif.). Fluorescein isothiocyanate,
phycoerythrin, and Cy-Chrome were excited with an ILT 5500A argon ion
laser (Ion Laser Technology, Salt Lake City, Utah). Cascade blue was
excited with 50 mW of all lines of UV light (351 to 365 nm wavelength). Electronic compensation for spectral overlap of the fluorochromes was
performed with single-color control samples prepared with the test
samples. All data presented were based on analysis of 2 × 104 cells with the Paint-A-Gate software (Becton
Dickinson). Analysis gates were set on isotype controls.
7-AAD staining.
Staining was performed with 0.0625 µg of
7-amino-actinomycin D (7-AAD) PharMingen added to 105 cells
in 100 µl of PBS. Cells were stained for 15 min at room temperature
(RT) in the dark, then brought to a final volume of 500 µl of PBS.
Samples were run within 1 h on the FACScan. Unstained cells were
used for a negative control. Data on 2 × 104 cells
were analyzed using the CELLQuest software. Scattergrams were generated
by combining forward light scatter with 7-AAD fluorescence. Regions of
clear-cut populations having negative, dim, and bright fluorescence
were selected.
DNA fragmentation assay.
Cellular DNA was extracted from
2 × 107 cells using the Apoptotic DNA Ladder kit
(Boehringer Mannheim). Cells were lysed in 200 µl of lysis buffer (6 M guanidine-HCl, 10 mM Tris-HCl, 10 mM urea, 20% Triton X-100 [pH
4.4]) and incubated for 10 min at RT. Samples subsequently were mixed
with 100 µl of isopropanol, filtered by centrifugation for 1 min at
8,000 rpm in an Eppendorf centrifuge, and washed twice. DNA was eluted
into 100 µl of 10 mM Tris-HCl (pH 8.5) buffer, and 1.5 µg of DNA
was electrophoresed through a 1.5% agarose gel for 1.5 h at 100 V
in 1× TBE (81 mM Tris base, 81 mM boric acid, 1.8 mM EDTA). DNA was
visualized by staining with ethidium bromide and examination under UV light.
Caspase-3 assay.
Cells (2 × 107) were
collected at each time point, washed twice with PBS, and lysed in 200 µl of 50 mM Tris-HCl (pH 7.5) containing 0.03% Nonidet and 1 mM
dithiothreitol. Nuclei were removed by centrifugation (1,200 × g) for 5 min, and 50 µl of the cytosolic fraction was
incubated with 40 µM DEVD-amc-10 mM HEPES (pH 7.5)-50 mM NaCl-2.5
mM dithiothreitol in a total volume of 200 µl for 120 min at 37°C.
Coumarin fluorescence, released by caspase cleavage of DEVD-amc, was
measured using 360-nm excitation and 415-nm emission wavelengths. A
charge-coupled device (Instaspec IV; Oriel, Stratford, Conn.) fitted
with a monochromator was used to measure the fluorescence emission
spectrum. The system was initially calibrated with known levels of
aminomethylcoumarin. Protein amounts were measured using the
bicinchoninic acid protein assay (Pierce). Units of enzyme activity are
expressed as picomoles of substrate hydrolyzed per microgram of protein
per hour.
PARP cleavage assay.
Cells (2 × 107) were
washed twice with PBS, lysed with buffer containing 2% sodium dodecyl
sulfate (SDS), 0.5 M Tris-HCl (pH 6.8), and 20% glycerol and
subsequently boiled for 5 min. Equal amounts of protein were loaded on
a 8% polyacrylamide gel and separated by electrophoresis at 120 V for
2 h. Following transfer, nitrocellulose membranes were reacted
with a poly(ADP-ribose) polymerase (PARP)-specific primary antibody
(C-2-10; BIOMOL Research Laboratory) for 1 h. After being washed
three times with 1× TTBS (0.2% Tween 20, 0.136 M NaCl, 2.7 mM KCl, 25 mM Tris-HCl [pH 7.4]; Sigma), the membrane was incubated with
horseradish peroxidase-conjugated rabbit anti-mouse IgG secondary
antibody for another hour at RT. Antigen was detected using the ECL
detection system (Pierce) according to the manufacturer's
instructions. Membranes were exposed to Kodak X-ray film.
 |
RESULTS |
Depletion of thymic T lymphocytes by MLV infection.
In our
studies of the pathogenic properties of the MCF13 MLV, we examined the
effect of virus infection on thymus size. We detected a significant
decrease in thymus weight at 8 weeks after MCF13 MLV inoculation of
neonatal AKR/J mice. The mean weight of thymuses from 23 mice at 8 weeks postinoculation (p.i.) was 110.3 ± 20.4 mg compared with a
mean weight of 128.2 ± 19.5 mg for 19 age-matched control
thymuses. The difference in thymus weights for MCF13-inoculated and
uninoculated mice was statistically significant, with a P
value of 0.003 as determined by Student's t test. We picked
8 weeks to examine thymus weight because at this time point we had
previously observed a maximum of 58% of virus-infected cells in the
thymus before thymic lymphoma first began to appear at 10 weeks p.i.
(54, 59).
To determine whether the difference in thymic weights was due to a
difference in cellularity, we performed a longitudinal study of the
effect of MCF13 MLV infection on thymic cell number. We started at 3 weeks p.i. to assess the total number of thymic cells because in a
previous study we observed that this was the earliest time after virus
inoculation when we could reproducibly detect virus-infected thymic
lymphocytes (59). By detection of the MCF13 envelope
glycoprotein (gp70) by flow cytometry, we observed that 8% of thymic
lymphocytes were infected by virus at 3 weeks p.i. (59). As
shown in Table 1, there was no difference in cell number for thymuses from MCF13-inoculated mice compared with
control animals at 3 and 4 weeks p.i. However, at later times after
virus inoculation, i.e., 6 and 8 weeks p.i., we observed a
statistically significant decrease in the number of lymphocytes isolated from thymuses from virus-inoculated mice compared with control
animals. We previously observed that at 6 weeks p.i., virus-infected
(gp70+) cells represented 52% of thymic lymphocytes, and
at 8 weeks p.i. this number increased slightly to 58% (59).
Thus, a decrease in thymus size and cell number correlated with an
increase in the number of MCF13 MLV-infected cells present in the
thymus.
Morphological lymphocyte depletion of thymic lymphocytes produced
by MCF13 MLV infection.
Because we detected a decrease in thymus
cellularity due to MCF13 MLV infection of this organ, we examined
thymic sections at 8 weeks p.i. by histological staining (Fig.
1). Sections from MCF13-inoculated mice
showed an overall decrease in lymphocyte numbers throughout the thymus
relative to control animals. At low magnification (e.g., Fig. 1), this
is apparent as a decrease in the intensity of hematoxylin staining for
the virus-infected thymus. This decrease in cellularity was most
pronounced in the CD4+ CD8+-rich cortical
regions.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 1.
Histological comparison of thymuses from
MCF13-inoculated and control mice. (A) The thymus of an 8-week-old
control mouse shows a thick zone of densely staining cortex (C) and a
small zone of lightly staining medulla (M). (B) Lymphocyte depletion of
the thymus is detectable 8 weeks after inoculation of MCF13 MLV.
|
|
Identification of thymic subpopulations which are depleted by MCF13
MLV infection.
The thymus comprises a number of different
subpopulations of T lymphocytes, which have been identified by their
differential expression of the CD3, CD4, and CD8 cell surface antigens
(14, 41, 44). To identify the subpopulation which was
reduced in number in thymuses from mice inoculated with MCF13 MLV, we
performed flow cytometric analysis of thymic lymphocytes stained with
anti-CD3, anti-CD4, and anti-CD8 fluorescent-labeled antibodies. We
examined the five predominant subpopulations in the thymus detectable
with these antibodies, as presented in Table
2. These subpopulations were the immature
CD3
CD4
CD8
,
CD3
CD4+ CD8+, and
CD3+ CD4+ CD8+ cells and the more
mature CD3+ CD4+ CD8
and
CD3+ CD4
CD8+ cells. Although
other investigators have identified additional subsets of thymic cells,
i.e., CD3
CD4+ CD8
,
CD3
CD4
CD8+, and
CD3+ CD4
CD8
(14, 23, 24,
44), their numbers were too few to be reproducibly detectable and
hence they were not included in our analysis.
The number of T lymphocytes in each of these five subpopulations was
determined from 3 to 8 weeks p.i. (Table
2). Similar
to our results
from examining total thymic lymphocytes as described
above, we detected
no difference in the numbers of any of the
subpopulations of cells
isolated from thymuses from MCF13-inoculated
mice compared with control
mice at 3 and 4 weeks p.i. However,
at both 6 and 8 weeks p.i. we
observed a statistically significant
decrease in the number of
lymphocytes present in the CD3

CD4
+
CD8
+ and CD3
+ CD4
+ CD8
+
subpopulations of thymuses from virus-inoculated mice. We detected
no
significant changes in the number of cells in the other three
subpopulations at any time. The depletion of these two subpopulations
correlated with results from a previous study in which we observed
that
the CD3

CD4
+ CD8
+ and
CD3
+ CD4
+ CD8
+ subpopulations had
the greatest number of virus-infected thymic
cells at 6 and 8 weeks
p.i. (
59). At 6 weeks p.i., gp70
+ cells
constituted 43% of the CD3

CD4
+
CD8
+ cells and 51% of the CD3
+
CD4
+ CD8
+ cells. At 8 weeks p.i.,
gp70
+ cells accounted for more than 50% of both
subpopulations. Thus,
the reduction in cell number in these two
subpopulations is mainly
responsible for the decrease in total thymic
cell numbers due
to MCF13 MLV
infection.
Thymic lymphocyte depletion involves apoptosis.
To better
understand the basis for the reduction in thymic cell number after
MCF13 MLV infection, we assessed the percentages of live,
apoptotic, and dead cells in thymuses at approximately 2 to 3 and 8 to 9 weeks after virus inoculation. These two time points were
selected because they corresponded to times when we detected either no
difference in total thymus cell number (3 weeks) or a significant
decrease in cell number (8 weeks) as described above (Table 1).
Isolated thymic lymphocytes were treated with 7-AAD to delineate live,
apoptotic, and late apoptotic/dead cells by flow
cytometry.
7-AAD is a fluorescent DNA-binding agent which others have
shown
is able to identify early apoptotic cells (7-AAD
dim), which retain
membrane integrity, from late apoptotic/dead
cells (7-AAD bright),
for which intact membrane permeability is altered
in contrast
to necrotic cells, which have lost membrane integrity
(
37,
43).
Live cells are 7-AAD negative. The ability of this
reagent to
discriminate among these cell populations is thought to be
due
to differential transport of the dye due to alterations in the
membranes of apoptotic and dead cells (
43). In Fig.
2 is shown
an example of a dot plot
depicting the three populations among
thymic lymphocytes.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of live, apoptotic, and dead cells by
7-AAD staining and flow cytometry. Thymic lymphocytes isolated from the
thymus of a 2-week-old AKR/J mouse and placed in culture for 24 h
were stained with 7-AAD. Stained cells (2 × 104) were
analyzed by a FACScan flow cytometer. The dot plot was generated with
the CELLQuest software. Selected regions are live (R1),
apoptotic (R2), and late apoptotic/dead (R3) cells. The
percentage of cells in each population is indicated.
|
|
We first examined thymic lymphocytes from mice at 2 weeks p.i. For
these cells we detected no difference among the percentages
of live,
apoptotic, and late apoptotic/dead cells between thymic
lymphocytes freshly isolated from MCF13 MLV-inoculated and control
mice
(0 h values in Table
3). Although the
brightly staining
population consists of a mixture of both late
apoptotic and dead
cells, we refer to this population simply as
dead in Table
3.
Because 7-AAD does not differentiate between late
apoptotic and
dead cells in the brightly staining population,
we also calculated
the sum of the percentages of apoptotic and
dead cells in Table
3 to obtain an approximate number of total
apoptotic cells which
were in both early and late apoptosis. At
8 weeks p.i., however,
we detected statistically significant
differences for the live,
dead, and sum of apoptotic and dead
cell populations between freshly
isolated thymic lymphocytes from
MCF13-inoculated mice and those
from control mice (0 h values).
For thymic lymphocytes from MCF13-inoculated
mice at 8 weeks p.i., we
detected a decrease in the percentage
of live cells and increases in
the percentages of dead and apoptotic
and dead cells compared
with those from age-matched control mice.
It has been observed that thymic lymphocytes undergo spontaneous
apoptosis when placed in culture (
39,
53). To determine
whether MCF13 infection has an effect on the survival of thymic
lymphocytes in vitro, we assessed the percentages of live,
apoptotic,
and dead cells that were placed in culture for 24 and 48 h. We
did not detect any differences among the three
populations between
virus-infected and control thymic lymphocytes at 2 weeks p.i.
except for dead cells at 48 h (Table
3). In contrast,
at 8 weeks
p.i. we observed a significant decrease in the percentage of
live
cells and increases in the percentage of apoptotic or dead
cells
for thymic lymphocytes from virus-inoculated mice compared with
control animals at 0, 24, and 48 h. Although our data showed that
thymic cells from control mice did undergo spontaneous apoptosis
in
culture over time, as observed by others, apoptosis was greater
for
cells from MCF13-inoculated animals. We also observed that
the
difference in the percentage of dead cells was greater than
that of
apoptotic cells between the thymuses from virus-inoculated
and
control mice. As discussed below, it appears that an increase
in
apoptosis, which occurs soon after these cells are isolated,
contributes to this increase in thymus cell
death.
Additional assays for apoptosis of thymic lymphocytes from
MCF13-inoculated mice.
We performed additional independent assays
for apoptosis to confirm the results from our 7-AAD analysis of freshly
isolated thymic lymphocytes as well as those that were placed in
culture. To determine whether the increase in apoptosis that we
observed for the cultured cells may be due to apoptotic events
which occur before 24 h, we included a 6-h time point in these
studies. Assays for apoptosis included assessments of DNA fragmentation
as well as cleavage of the proenzymes PARP and procaspase-3. All three cellular events are hallmarks of apoptosis in various types of cells,
including lymphocytes (1, 7, 11). Again, we analyzed thymic
lymphocytes which were isolated from mice at 8 weeks after virus inoculation.
We first examined nuclear DNA degradation by internucleosomal cleavage,
which has been shown to occur in thymic lymphocytes
undergoing
apoptosis (
45,
48). Our analysis of total cellular
DNA
isolated from thymic cells showed an increase in DNA degradation
to
oligonucleosomal fragments, referred to as fragmentation, for
lymphocytes isolated from MCF13 virus-inoculated mice compared
with
those from control mice (Fig.
3). Our
data indicated that
although differences in DNA fragmentation were
already apparent
in freshly isolated thymic cells (0 h), this
difference was even
greater starting at 6 h after the cells were
placed in culture.
In addition, we continued to detect significant
differences in
DNA fragmentation between thymic cells isolated from
virus-inoculated
and control mice at 24 and 48 h in vitro.

View larger version (127K):
[in this window]
[in a new window]
|
FIG. 3.
DNA fragmentation of thymic lymphocytes. Cellular DNA
(1.5 µg) isolated from thymic lymphocytes with the Apoptotic DNA
Ladder kit (Boehringer Mannheim) was electrophoresed in each well of a
1.5% agarose gel at 100 V for 1.5 h. DNA was extracted from
pooled lymphocytes from thymuses of three mice which were either
control (C) or inoculated with MCF13 MLV for 8 weeks (MLV). Thymic
cells were placed in culture for 0, 6, 24, and 48 h before DNA
extraction. Lane M, 100-bp DNA ladder (Gibco-BRL). Three independent
assays which were performed with different pools of thymic lymphocytes
yielded similar results.
|
|
Additional independent assays, which were performed to detect apoptosis
of thymic lymphocytes, included the detection of caspase-3
and PARP
proenzyme cleavage. The same pooled thymic cells which
were analyzed
for DNA fragmentation were also used for these enzymatic
assays. It has
been observed that cleavage of both procaspase-3
and PARP occurs before
DNA fragmentation during cellular apoptosis
(
20). We first
assayed the enzymatic activity of caspase-3,
a cysteine protease, by
using the DEVD-amc fluorogenic substrate
(
32). Enzyme
activity was measured in five independent experiments
performed at
different times as described in Materials and Methods.
The ratio of
caspase-3 activity detected for thymic cells from
control versus
virus-inoculated mice was then calculated. The
mean of these ratios for
freshly isolated thymic cells was 3.0,
with a range of 1.8 to 4.3. At
6 h in culture, the mean ratio
increased to 7.0, with a range of
2.6 to 11.1. The mean ratios
of caspase-3 activities for cells placed
in culture for 24 and
48 h were 1.1 (range, 0.5 to 1.8) and 0.7 (range, 0.4 to 1.2),
respectively. Thus, we detected an increase in
caspase-3 activity
which peaked at 6 h after culturing for thymic
cells isolated
from MCF13-inoculated mice compared with cells from
control mice.
These data are consistent with the observation by others
that
the activation of caspase-3 is an early event in apoptosis
(
7).
We next assessed the cleavage of the 116-kDa PARP proenzyme into 85- and 31-kDa products (
25,
50). The 85-kDa cleavage
product
contains the catalytic subunit (
11). As shown in Fig.
4, we detected a greater amount of the
85-kDa cleavage product
for thymic lymphocytes isolated from
MCF13-inoculated mice than
for those from control mice starting at
6 h of culture. Similar
results were obtained for cells in culture
for 24 h. Thus, the
data from three different assays for apoptosis
corroborated our
results from the flow cytometric analysis of thymic
cells by 7-AAD
staining (Tables
1 and
2) and support the idea that
MCF-13 MLV
infection of thymic lymphocytes induces apoptosis in these
cells.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Assay of PARP cleavage. Equal amounts of cellular
protein were electrophoresed through an SDS-8% polyacrylamide gel for
2 h at 120 V. The uncleaved 116-kDa and 85-kDa cleavage products
of PARP were detected by immunoblotting with the C-2-10 antibody
(BIOMOL Research Laboratory). Cellular protein was extracted from
pooled lymphocytes from thymuses of three mice which were either
control (C) or inoculated with MCF13 MLV for 8 weeks (MLV). Thymic
cells were placed in culture for 0, 6, and 24 h before protein
extraction. This immunoblot is representative of three independent
assays performed at different times.
|
|
Increase in apoptosis of thymic lymphocytes correlates with MCF13
MLV infection.
To better determine whether MCF13 virus infection
of thymic cells affects their ability to undergo cell death caused by
apoptosis, we stained cells with 7-AAD and MAb 514 (13),
which specifically detects MCF envelope glycoproteins. By flow
cytometric analysis we selected cells expressing MCF glycoprotein
(gp70+) and those which were negative for glycoprotein
expression (gp70
). We then assessed the percentage of
live, apoptotic, and dead cells in both of these populations of
cells. Because we did not detect any difference between thymic
lymphocytes isolated from virus-inoculated and control mice at 2 weeks
p.i., we performed this analysis only at 8 weeks p.i. Furthermore, we
analyzed only freshly isolated thymic lymphocytes because we observed
that cells in culture were sensitive to the additional manipulations
required for gp70 detection, which resulted in additional cell death
for reasons that are not understood. As shown in Table
4, we observed significant differences
between the gp70+ and gp70
cells in all cell
populations examined. The percentages of apoptotic and dead
cells were significantly higher, as determined by statistical analysis,
for the gp70+ cells compared with the gp70
population. We also detected a concomitant decrease in the percentage of live gp70+ cells. Thus, MCF13 MLV infection of thymic
lymphocytes leads to an increase in their ability to undergo cell
death.
 |
DISCUSSION |
We have shown that MCF13 MLV infection of thymic lymphocytes
during the preleukemic period results in an increase in cellular apoptosis as measured by several independent assays. Our data suggest
that this increase in apoptosis is responsible for the decrease in
thymus cellularity which mainly affects the CD3
CD4+ CD8+ and CD3+ CD4+
CD8+ subpopulations of immature thymic lymphocytes. We have
previously shown that these are the same two subpopulations which are
predominantly infected by the MCF13 virus (59). A decrease
in the percentage of CD4+ CD8+ cells has also
been implicated in the development of thymic tumors by the SL3-3 MLV
(16, 17). Our detection of an increase in apoptosis and dead
cells for freshly isolated gp70+ cells compared with
gp70
cells supports the notion that virus infection is
directly responsible for cellular apoptosis and subsequent death. The
receptor protein for the MCF glycoprotein is closely related to the
yeast SYG1 protein (2, 49, 58), which induces transient cell
cycle arrest in response to the yeast mating pheromone (46).
Whether the mammalian homolog of the SYG1 protein is part of a signal transduction pathway that is involved in the induction of apoptosis of
virus-infected cells remains to be determined.
It is interesting that the same subpopulations in the thymus which are
depleted by MCF13 MLV infection are those which undergo positive and
negative selection (15, 22, 30). The majority of cells in
these subpopulations, which together comprise 80 to 90% of total
thymic lymphocytes (14, 41), are eliminated by apoptosis
within a few days of development in the thymus (29). The
CD4+ CD8+ cells are mainly present in the
cortical regions of the thymus. Our results of a histological
examination of the thymus after MCF13 virus inoculation showed
lymphocyte depletion predominantly of the cortical regions, which
correlated with our detection of reduced numbers of CD4+
CD8+ cells in virus-infected animals. This observation is
corroborated by an earlier study which showed that thymuses from
6-month-old AKR mice undergo cortical involution during the development
of spontaneous tumors in these animals (33).
It has been shown that tumorigenesis in the AKR mouse is a complex
phenomenon, which also involves a role of the thymic stroma. During the
development of both spontaneous and SL3-3 MLV-induced disease, it has
been shown that virus infection of thymic stromal cells affects
T-lymphocyte maturation (10, 16, 17). Virus infection of the
CD4+ CD8+ cells may contribute to an alteration
in the interactions of thymic lymphocytes with stromal epithelial
cells, thus possibly resulting in abnormal maturation of the
virus-infected cells.
Although both the inhibition and induction of apoptosis have
been implicated in tumorigenesis, it has been most commonly observed that the development of malignancies is dependent upon an initial inhibition of apoptosis (3, 31, 56). In contrast, we
have demonstrated that the development of thymic tumors by MCF MLV infection results in an enhancement of apoptosis during the
early stages of lymphomagenesis. Induction of apoptosis as an
early event in cellular transformation has been observed for other
oncogenic retroviruses as well. Fan and coworkers have shown that the
Moloney MLV, which also generates thymic tumors, increased thymic
cell apoptosis also during the preleukemic period
(4). Their data furthermore demonstrated that the level of
cellular apoptosis correlated with viral pathogenicity. Another
example includes the subgroups B and D avian leukosis viruses, which
cause high levels of cell death during the acute phase of infection
(55). This viral cytopathicity has been attributed to the
binding of the avian leukosis virus glycoprotein to the receptor
molecule CAR1, which is a member of the tumor necrosis factor receptor family (5). Other examples of the induction of
apoptosis during cellular transformation include the
transformation of pre-B cells in vitro by the Abelson murine leukemia
virus (38, 52) and of T cells by the feline leukemia virus
subgroup C (40).
For the induction of thymic tumors by MCF13 MLV, we hypothesize that
cells which survive the apoptotic crisis induced by virus infection are those which will evolve into a fully malignant cell. It
is likely that the progression to a tumor cell requires the inheritance
of multiple genetic mutations, some of which result in the inhibition
of apoptosis. An example of such an event is proviral
insertional mutagenesis of the c-myc protooncogene, which occurs at a significant frequency in thymic tumors induced by various
murine leukemia viruses. It has been shown that overexpression of
c-myc can rescue lymphocytes from apoptosis
(19, 57). Additional genetic mutations involving other
cellular proteins which are able to rescue cells from
apoptosis, such as members of the Bcl-2 and NF-
B families,
may also play a role in the development of MLV-induced thymic tumors.
Our detection of an increase in NF-
B in MCF13-induced tumors by 50- to 200-fold compared with normal thymuses would support this idea
(unpublished results). It is noteworthy that NF-
B and c-Myc have
synergistic roles in inhibiting apoptosis for certain cell
types (42). Our results suggest that the induction of
apoptosis as an early event in the development of lymphomas may
be a common mechanism used by different transforming retroviruses.
 |
ACKNOWLEDGMENTS |
We thank Yihua Zhang and Younong Min for excellent technical
assistance. Eric Van Buren's help in performing the flow cytometry experiments is greatly appreciated. We also thank Gangyong Li for
assistance in the PARP assays and Chris Brantley for assistance in
preparing the histological sections.
This work was supported by Public Health Service grants from
the National Institutes of Health (CA44166 to F.K.Y., CA64139 to
H.-R.C.K., and DK02503 to J.R.T.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Immunology and Microbiology, Wayne State University, 540 E. Canfield, Detroit, MI 48201. Phone: (313) 577-1571. Fax: (313) 577-1155. E-mail:
fyoshi{at}med.wayne.edu.
 |
REFERENCES |
| 1.
|
Allen, P. D., and A. C. Newland.
1998.
Electrophoretic DNA analysis for the detection of apoptosis.
Mol. Biotechnol.
9:247-251[Medline].
|
| 2.
|
Battini, J. L.,
J. E. Rasko, and A. D. Miller.
1999.
A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction.
Proc. Natl. Acad. Sci. USA
96:1385-1390[Abstract/Free Full Text].
|
| 3.
|
Bedi, A.,
P. J. Pasricha,
A. J. Akhtar,
J. P. Barber,
G. C. Bedi,
F. M. Giardiello,
B. A. Zehnbauer,
S. R. Hamilton, and R. J. Jones.
1995.
Inhibition of apoptosis during development of colorectal cancer.
Cancer Res.
55:1811-1816[Abstract/Free Full Text].
|
| 4.
|
Bonzon, C., and H. Fan.
1999.
Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.
J. Virol.
73:2434-2441[Abstract/Free Full Text].
|
| 5.
|
Brojatsch, J.,
J. Naughton,
M. M. Rolls,
K. Zingler, and J. A. Young.
1996.
CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis.
Cell
87:845-855[CrossRef][Medline].
|
| 6.
|
Cloyd, M. W.,
J. W. Hartley, and W. P. Rowe.
1980.
Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses.
J. Exp. Med.
151:542-552[Abstract/Free Full Text].
|
| 7.
|
Cohen, G. M.
1997.
Caspases: the executioners of apoptosis.
Biochem J.
326:1-16.
|
| 8.
|
Corcoran, L. M.,
J. M. Adams,
A. R. Dunn, and S. Cory.
1984.
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion.
Cell
37:113-122[CrossRef][Medline].
|
| 9.
|
Cuypers, H. T.,
G. Selten,
W. Quint,
M. Zijlstra,
E. R. Maandag,
W. Boelens,
P. van Wezenbeek,
C. Melief, and A. Berns.
1984.
Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.
Cell
37:141-150[CrossRef][Medline].
|
| 10.
|
Davey, G. M.,
C. L. Tucek-Szabo, and R. L. Boyd.
1996.
Characterization of the AKR thymic microenvironment and its influence on thymocyte differentiation and lymphoma development.
Leukocyte Res.
20:853-866.
|
| 11.
|
Duriez, P. J., and G. M. Shah.
1997.
Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death.
Biochem. Cell Biol.
75:337-349[CrossRef][Medline].
|
| 12.
|
Evans, L. H., and F. G. Malik.
1987.
Class II polytropic murine leukemia viruses (MuLVs) of AKR/J mice: possible role in the generation of class I oncogenic polytropic MuLVs.
J. Virol.
61:1882-1892[Abstract/Free Full Text].
|
| 13.
|
Evans, L. H.,
R. P. Morrison,
F. G. Malik,
J. Portis, and W. J. Britt.
1990.
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.
J. Virol.
64:6176-6183[Abstract/Free Full Text].
|
| 14.
|
Fowlkes, B. J., and D. M. Pardoll.
1989.
Molecular and cellular events of T cell development.
Adv. Immunol.
44:207-264[Medline].
|
| 15.
|
Fowlkes, B. J.,
R. H. Schwartz, and D. M. Pardoll.
1988.
Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage.
Nature
334:620-623[CrossRef][Medline].
|
| 16.
|
Hays, E. F.,
G. Bristol, and S. McDougall.
1990.
Mechanisms of thymic lymphomagenesis by the retrovirus SL3-3.
Cancer Res.
50:5631s-5635s[Abstract/Free Full Text].
|
| 17.
|
Hays, E. F.,
G. C. Bristol,
J. P. Lugo, and X. F. Wang.
1989.
Progression to development of lymphoma in the thymus of AKR mice treated neonatally with SL3-3 virus.
Exp. Hematol.
17:1116-1121[Medline].
|
| 18.
|
Hays, E. F.,
G. C. Bristol,
S. McDougall,
J. L. Klotz, and M. Kronenberg.
1989.
Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL3-3.
Cancer Res.
49:4225-4230[Abstract/Free Full Text].
|
| 19.
|
Hermann, M.,
H. J. Scholman,
T. Marafioti,
H. Stein, and F. Schriever.
1997.
Differential expression of apoptosis, Bcl-x and c-Myc in normal and malignant lymphoid tissues.
Eur. J. Haematol.
59:20-30[Medline].
|
| 20.
|
Kaufmann, S. H.,
S. Desnoyers,
Y. Ottaviano,
N. E. Davidson, and G. G. Poirier.
1993.
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
Cancer Res.
53:3976-3985[Abstract/Free Full Text].
|
| 21.
|
Kawashima, K.,
H. Ikeda,
J. W. Hartley,
E. Stockert,
W. P. Rowe, and L. J. Old.
1976.
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice.
Proc. Natl. Acad. Sci. USA
73:4680-4684[Abstract/Free Full Text].
|
| 22.
|
Kisielow, P.,
H. Bluthmann,
U. D. Staerz,
M. Steinmetz, and H. von Boehmer.
1988.
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.
Nature
333:742-746[CrossRef][Medline].
|
| 23.
|
Kraft, D. L.,
I. L. Weissman, and E. K. Waller.
1993.
Differentiation of CD3 4 8 human fetal thymocytes in vivo: characterization of a CD3 4+8 intermediate.
J. Exp. Med.
178:265-277[Abstract/Free Full Text].
|
| 24.
|
Kydd, R.,
K. Lundberg,
D. Vremec,
A. Harris, and K. Shortman.
1995.
Intermediate steps in thymic positive selection.
J. Immunol.
155:3806-3814[Abstract].
|
| 25.
|
Lazebnik, Y. A.,
S. H. Kaufmann,
S. Desnoyers,
G. G. Poirier, and W. C. Earnshaw.
1994.
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.
Nature
371:346-347[CrossRef][Medline].
|
| 26.
|
Lazo, P. A.,
A. J. P. Klein-Szanto, and P. N. Tsichlis.
1990.
T-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implications.
J. Virol.
64:3948-3959[Abstract/Free Full Text].
|
| 27.
|
Lenz, J.,
D. Celander,
R. L. Crowther,
R. Patarca,
D. W. Perkins, and W. A. Haseltine.
1984.
Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.
Nature
308:467-470[CrossRef][Medline].
|
| 28.
|
Lung, M. L.,
J. W. Hartley,
W. P. Rowe, and N. H. Hopkins.
1983.
Large RNase T1-resistant oligonucleotides encoding p15E and the U3 region of the long terminal repeat distinguish two biological classes of mink cell focus-forming type C viruses of inbred mice.
J. Virol.
45:275-290[Abstract/Free Full Text].
|
| 29.
|
McPhee, D.,
J. Pye, and K. Shortman.
1979.
The differentiation of T lymphocytes. V. Evidence for intrathymic death of most thymocytes.
Thymus
1:151-162[Medline].
|
| 29a.
|
Metcalf, D.
1966.
The thymus.
Rec. Results Cancer Res.
5:1-144.
|
| 30.
|
Murphy, K. M.,
A. B. Heimberger, and D. Y. Loh.
1990.
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.
Science
250:1720-1723[Abstract/Free Full Text].
|
| 31.
|
Naik, P.,
J. Karrim, and D. Hanahan.
1996.
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.
Genes Dev.
10:2105-2116[Abstract/Free Full Text].
|
| 32.
|
Nicholson, D. W.,
A. Ali,
N. A. Thornberry,
J. P. Vaillancourt,
C. K. Ding,
M. Gallant,
Y. Gareau,
P. R. Griffin,
M. Labelle,
Y. A. Lazebnik, et al.
1995.
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
Nature
376:37-43[CrossRef][Medline].
|
| 33.
|
Nowinski, R. C., and T. Doyle.
1977.
Cellular changes in the thymuses of preleukemic AKR mice: correlation with changes in the expression of murine leukemia viruses.
Cell
12:341-353[CrossRef][Medline].
|
| 34.
|
O'Donnell, P. V.,
E. Stockert,
Y. Obata, and L. J. Old.
1981.
Leukemogenic properties of AKR dualtropic (MCF) viruses: amplification of murine leukemia virus-related antigens on thymocytes and acceleration of leukemia development in AKR mice.
Virology
112:548-563[CrossRef][Medline].
|
| 35.
|
O'Donnell, P. V.,
R. C. Nowinski, and E. Stockert.
1982.
Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV.
Virology
119:450-464[CrossRef][Medline].
|
| 36.
|
Peters, G.
1990.
Oncogenes at viral integration sites.
Cell Growth Differ.
1:503-510[Medline].
|
| 37.
|
Philpott, N. J.,
A. J. Turner,
J. Scopes,
M. Westby,
J. C. Marsh,
E. C. Gordon-Smith,
A. G. Dalgleish, and F. M. Gibson.
1996.
The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques.
Blood
87:2244-2251[Abstract/Free Full Text].
|
| 38.
|
Radfar, A.,
I. Unnikrishnan,
H. W. Lee,
R. A. DePinho, and N. Rosenberg.
1998.
p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.
Proc. Natl. Acad. Sci. USA
95:13194-13199[Abstract/Free Full Text].
|
| 39.
|
Rinner, I.,
P. Felsner,
D. Hofer,
A. Globerson, and K. Schauenstein.
1996.
Characterization of the spontaneous apoptosis of rat thymocytes in vitro.
Int. Arch. Allergy Immunol.
111:230-237[Medline].
|
| 40.
|
Rojko, J. L.,
R. M. Fulton,
L. J. Rezanka,
L. L. Williams,
E. Copelan,
C. M. Cheney,
G. S. Reichel,
J. C. Neil,
L. E. Mathes,
T. G. Fisher, et al.
1992.
Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells.
Lab. Investig.
66:418-426[Medline].
|
| 41.
|
Rothenberg, E. V.
1992.
The development of functionally responsive T cells.
Adv. Immunol.
58:85-214.
|
| 42.
|
Schauer, S. L.,
Z. Wang,
G. E. Sonenshein, and T. L. Rothstein.
1996.
Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
J. Immunol.
157:81-86[Abstract].
|
| 43.
|
Schmid, I.,
C. H. Uittenbogaart,
B. Keld, and J. V. Giorgi.
1994.
A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry.
J. Immunol. Methods
170:145-157[CrossRef][Medline].
|
| 44.
|
Scollay, R.
1991.
T-cell subset relationships in thymocyte development.
Curr. Opin. Immunol.
3:204-209[CrossRef][Medline].
|
| 45.
|
Shi, Y. F.,
R. P. Bissonnette,
N. Parfrey,
M. Szalay,
R. T. Kubo, and D. R. Green.
1991.
In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes.
J. Immunol.
146:3340-3346[Abstract].
|
| 46.
|
Spain, B. H.,
D. Koo,
M. Ramakrishnan,
B. Dzudzor, and J. Colicelli.
1995.
Truncated forms of a novel yeast protein suppress the lethality of a G protein alpha subunit deficiency by interacting with the beta subunit.
J. Biol. Chem.
270:25435-25444[Abstract/Free Full Text].
|
| 47.
|
Stoye, J. P.,
C. Moroni, and J. M. Coffin.
1991.
Virological events leading to spontaneous AKR thymomas.
J. Virol.
65:1273-1285[Abstract/Free Full Text].
|
| 48.
|
Tadakuma, T.,
H. Kizaki,
C. Odaka,
R. Kubota,
Y. Ishimura,
H. Yagita, and K. Okumura.
1990.
CD4+CD8+ thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody.
Eur. J. Immunol.
20:779-784[Medline].
|
| 49.
|
Tailor, C. S.,
A. Nouri,
C. G. Lee,
C. Kozak, and D. Kabat.
1999.
Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses.
Proc. Natl. Acad. Sci. USA
96:927-932[Abstract/Free Full Text].
|
| 50.
|
Tewari, M.,
L. T. Quan,
K. O'Rourke,
S. Desnoyers,
Z. Zeng,
D. R. Beidler,
G. G. Poirier,
G. S. Salvesen, and V. M. Dixit.
1995.
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.
Cell
81:801-809[CrossRef][Medline].
|
| 51.
|
Thomas, C. Y., and J. M. Coffin.
1982.
Genetic alterations of RNA leukemia viruses associated with the development of spontaneous thymic leukemia in AKR/J mice.
J. Virol.
43:416-426[Abstract/Free Full Text].
|
| 52.
|
Thome, K. C.,
A. Radfar, and N. Rosenberg.
1997.
Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells.
J. Virol.
71:8149-8156[Abstract].
|
| 53.
|
Tiso, M.,
R. Gangemi,
A. Bargellesi Severi,
S. Pizzolitto,
M. Fabbi, and A. Risso.
1995.
Spontaneous apoptosis in human thymocytes.
Am. J. Pathol.
147:434-444[Abstract].
|
| 54.
|
Tupper, J. C.,
H. Chen,
E. F. Hays,
G. C. Bristol, and F. K. Yoshimura.
1992.
Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
J. Virol.
66:7080-7088[Abstract/Free Full Text].
|
| 55.
|
Weller, S. K., and H. M. Temin.
1981.
Cell killing by avian leukosis viruses.
J. Virol.
39:713-721[Abstract/Free Full Text].
|
| 56.
|
Williams, G. T.
1991.
Programmed cell death: apoptosis and oncogenesis.
Cell
65:1097-1098[CrossRef][Medline].
|
| 57.
|
Wu, M.,
W. Yang,
R. E. Bellas,
S. L. Schauer,
M. J. FitzGerald,
H. Lee, and G. E. Sonenshein.
1997.
c-myc promotes survival of WEHI 231 B lymphoma cells from apoptosis.
Curr. Top. Microbiol. Immunol.
224:91-101[Medline].
|
| 58.
|
Yang, Y. L.,
L. Guo,
S. Xu,
C. A. Holland,
T. Kitamura,
K. Hunter, and J. M. Cunningham.
1999.
Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1.
Nat. Genet.
21:216-219[CrossRef][Medline].
|
| 59.
|
Yoshimura, F. K.,
T. Wang, and M. Cankovic.
1999.
Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.
J. Virol.
73:4890-4898[Abstract/Free Full Text].
|
Journal of Virology, September 2000, p. 8119-8126, Vol. 74, No. 17
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yoshimura, F. K., Luo, X., Zhao, X., Gerard, H. C., Hudson, A. P.
(2008). Up-regulation of a cellular protein at the translational level by a retrovirus. Proc. Natl. Acad. Sci. USA
105: 5543-5548
[Abstract]
[Full Text]
-
Zhao, X., Yoshimura, F. K.
(2008). Expression of Murine Leukemia Virus Envelope Protein Is Sufficient for the Induction of Apoptosis. J. Virol.
82: 2586-2589
[Abstract]
[Full Text]
-
Yoshimura, F. K., Luo, X.
(2007). Induction of Endoplasmic Reticulum Stress in Thymic Lymphocytes by the Envelope Precursor Polyprotein of a Murine Leukemia Virus during the Preleukemic Period. J. Virol.
81: 4374-4377
[Abstract]
[Full Text]
-
Nanua, S., Yoshimura, F. K.
(2004). Mink Epithelial Cell Killing by Pathogenic Murine Leukemia Viruses Involves Endoplasmic Reticulum Stress. J. Virol.
78: 12071-12074
[Abstract]
[Full Text]
-
Nanua, S., Yoshimura, F. K.
(2004). Differential Cell Killing by Lymphomagenic Murine Leukemia Viruses Occurs Independently of p53 Activation and Mitochondrial Damage. J. Virol.
78: 5088-5096
[Abstract]
[Full Text]
-
Rulli, K., Lenz, J., Levy, L. S.
(2002). Disruption of Hematopoiesis and Thymopoiesis in the Early Premalignant Stages of Infection with SL3-3 Murine Leukemia Virus. J. Virol.
76: 2363-2374
[Abstract]
[Full Text]
-
Yoshimura, F. K., Wang, T., Nanua, S.
(2001). Mink Cell Focus-Forming Murine Leukemia Virus Killing of Mink Cells Involves Apoptosis and Superinfection. J. Virol.
75: 6007-6015
[Abstract]
[Full Text]